Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A et al (2016) Pembrolizumab versus chemotherapy for PD-L1-Positive Non-small-cell lung cancer. N Engl J Med 375:1823–1833

Article  CAS  PubMed  Google Scholar 

Boyero L, Sanchez-Gastaldo A, Alonso M, Noguera-Ucles JF, Molina-Pinelo S, Bernabe-Caro R (2020) Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy. Cancers (Basel). https://doi.org/10.3390/cancers12123729

Article  PubMed  Google Scholar 

Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S et al (2016) Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 375:819–829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A et al (2018) Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer. Cancer Cell 33(843–52):e4

Google Scholar 

Chen X, Pan X, Zhang W, Guo H, Cheng S, He Q et al (2020) Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses. Acta Pharm Sin B 10:723–733

Article  CAS  PubMed  Google Scholar 

Shergold AL, Millar R, Nibbs RJB (2019) Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade. Pharmacol Res 145:104258

Article  CAS  PubMed  Google Scholar 

Zhang Z, Liu S, Zhang B, Qiao L, Zhang Y, Zhang Y (2020) T cell dysfunction and exhaustion in cancer. Front Cell Dev Biol 8:17

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Iams WT, Porter J, Horn L (2020) Immunotherapeutic approaches for small-cell lung cancer. Nat Rev Clin Oncol 17:300–312

Article  PubMed  PubMed Central  Google Scholar 

Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP et al (2018) The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 9:356

Article  PubMed  PubMed Central  Google Scholar 

Hao C, Lane J, Jiang WG (2023) Osteopontin and cancer: insights into its role in drug resistance. Biomedicines 11(1):197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Yang J, Liu H, Bi JR, Liu Y, Chen YY et al (2015) The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts. Onco Targets Ther 8:3513–3521

CAS  PubMed  PubMed Central  Google Scholar 

Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F et al (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378:2078–2092

Article  CAS  PubMed  Google Scholar 

Hanna NH, Schneider BJ, Temin S, Baker S Jr, Brahmer J, Ellis PM et al (2020) Therapy for stage iv non-small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update. J Clin Oncol 38:1608–1632

Article  PubMed  Google Scholar 

Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18:e143–e152

Article  PubMed  PubMed Central  Google Scholar 

Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R et al (2008) Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal 46:18–29

Article  CAS  PubMed  Google Scholar 

Carbone F, Grossi F, Bonaventura A, Vecchie A, Minetti S, Bardi N et al (2019) Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. Clin Exp Metastasis 36:449–456

Article  CAS  PubMed  Google Scholar 

Ministrini S, Andreozzi F, Montecucco F, Minetti S, Bertolotto M, Liberale L et al (2021) Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes. Eur J Clin Invest 51:e13640

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fidler MJ, Fhied CL, Roder J, Basu S, Sayidine S, Fughhi I et al (2018) The serum-based VeriStrat(R) test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer 18:310

Article  PubMed  PubMed Central  Google Scholar 

Du Y, Mao L, Wang Z, Yan K, Zhang L, Zou J (2022) Osteopontin - The stirring multifunctional regulatory factor in multisystem aging. Front Endocrinol (Lausanne) 13:1014853

Article  PubMed  Google Scholar 

Schafer MJ, Zhang X, Kumar A, Atkinson EJ, Zhu Y, Jachim S et al (2020) The senescence-associated secretome as an indicator of age and medical risk. JCI Insight. https://doi.org/10.1172/jci.insight.133668

Article  PubMed  PubMed Central  Google Scholar 

Komici K, Bencivenga L, Navani N, D’Agnano V, Guerra G, Bianco A et al (2022) Frailty in patients with lung cancer: a systematic review and meta-analysis. Chest 162:485–497

Article  PubMed  Google Scholar 

Scott JM, Stene G, Edvardsen E, Jones LW (2020) Performance status in cancer: not broken, but time for an upgrade? J Clin Oncol 38:2824–2829

Article  PubMed  PubMed Central  Google Scholar 

Moth EB, Kiely BE, Stefanic N, Naganathan V, Martin A, Grimison P et al (2019) Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer. J Geriatr Oncol 10:210–215

Article  PubMed  Google Scholar 

Jensen CE, Vohra SN, Nyrop KA, Deal AM, Muss HB, Lichtman EI et al (2022) Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. J Geriatr Oncol 13:182–189

Article  CAS  PubMed  Google Scholar 

Suto H, Inui Y, Okamura A (2022) Validity of the cancer and aging research group predictive tool in older Japanese patients. Cancers (Basel). https://doi.org/10.3390/cancers14092075

Article  PubMed  Google Scholar 

Frelaut M, Paillaud E, Beinse G, Scain AL, Culine S, Tournigand C et al (2023) External validity of two scores for predicting the risk of chemotherapy toxicity among older patients with solid tumors: results from the ELCAPA prospective cohort. Oncologist. https://doi.org/10.1093/oncolo/oyad050

Article  PubMed  PubMed Central  Google Scholar 

Zhai WY, Duan FF, Chen S, Wang JY, Zhao ZR, Wang YZ et al (2022) An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma. Front Cell Dev Biol 10:770550

Article  PubMed  PubMed Central  Google Scholar 

Domen A, Deben C, De Pauw I, Hermans C, Lambrechts H, Verswyvel J et al (2022) Prognostic implications of cellular senescence in resected non-small cell lung cancer. Transl Lung Cancer Res 11:1526–1539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen B, Liang Y, Chen L, Wei Y, Li Y, Zhao W et al (2018) Overexpression of klotho inhibits HELF fibroblasts SASP-related protumoral effects on non-small cell lung cancer cells. J Cancer 9:1248–1258

Article  PubMed  PubMed Central  Google Scholar 

Xu W, Li Y, Yuan WW, Yin Y, Song WW, Wang Y et al (2018) Membrane-bound CD40L promotes senescence and initiates senescence-associated secretory phenotype via NF-kappaB activation in lung adenocarcinoma. Cell Physiol Biochem 48:1793–1803

Article  CAS  PubMed  Google Scholar 

Gong L, Cui D, Liu D, Shen X, Pan H, Xiong X et al (2022) FBXW7 inactivation induces cellular senescence via accumulation of p53. Cell Death Dis 13:788

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tesei A, Arienti C, Bossi G, Santi S, De Santis I, Bevilacqua A et al (2021) TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer. J Exp Clin Cancer Res 40:89

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma A, Almasan A (2021) Autophagy and PTEN in DNA damage-induced senescence. Adv Cancer Res 150:249–284

Article  CAS  PubMed  Google Scholar 

Patil S, Reedy JL, Scroggins BT, White AO, Kwon S, Shankavaram U et al (2022) Senescence-associated tumor growth is promoted by 12-lipoxygenase. Aging (Albany NY) 14:1068–1086

Article  CAS  PubMed  Google Scholar 

Kong P, Yang X, Zhang Y, Dong H, Liu X, Xu X et al (2022) Palbociclib enhances migration and invasion of cancer cells via senescence-associated secretory phenotype-related CCL5 in non-small-cell lung cancer. J Oncol 2022:2260625

Article  PubMed  PubMed Central  Google Scholar 

Zhang B, Fu D, Xu Q, Cong X, Wu C, Zhong X et al (2018) The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involvin